Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS

doug jennings headshot talking therapeutics
Talking Therapeutics
Reassuring Data on Testosterone Safety
06/28/2023
This week, Dr Jennings examines a new study that reviews the benefit of testosterone replacement among men with hypogonadism.
This week, Dr Jennings examines a new study that reviews the benefit of testosterone replacement among men with hypogonadism.
This week, Dr Jennings examines...
06/28/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Entering 2023 With Hope for Targeted Therapies
01/05/2023
Dr Jennings discusses new agents for hypertrophic obstructive cardiomyopathy and Alzheimer disease that are intended to treat underlying disease mechanisms rather than symptoms.
Dr Jennings discusses new agents for hypertrophic obstructive cardiomyopathy and Alzheimer disease that are intended to treat underlying disease mechanisms rather than symptoms.
Dr Jennings discusses new agents...
01/05/2023
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Targeting Triglycerides to Treat Residual CV Risk
08/04/2021
Dr Jennings discusses updated guidelines for the treatment of hypertriglyceridemia, recently published by the American College of Cardiology and American Heart Association, in this week’s Talking Therapeutics.
Dr Jennings discusses updated guidelines for the treatment of hypertriglyceridemia, recently published by the American College of Cardiology and American Heart Association, in this week’s Talking Therapeutics.
Dr Jennings discusses updated...
08/04/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
COVID-19 Vaccines: Time to Boost Yet Again?
03/31/2022
In the latest installment of Talking Therapeutics, Dr Jennings explores administering a fourth COVID-19 vaccine dose in light of new research on the second booster's efficacy.
In the latest installment of Talking Therapeutics, Dr Jennings explores administering a fourth COVID-19 vaccine dose in light of new research on the second booster's efficacy.
In the latest installment of...
03/31/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
What’s the Deal With Xenotransplantation?
11/04/2022
Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world.
Dr Jennings discusses the potential of xenotransplantation, the transplant of nonhuman tissues and organs into a human recipient, for alleviating organ scarcity across the world.
Dr Jennings discusses the...
11/04/2022
Pharmacy Learning Network
Talking Therapeutics
A Watershed Moment for Weight Loss
11/22/2023
In this week's issue, Dr Jennings discusses the rates of obesity and how GLP-1 agonists may be vital in treating patients with obesity who have cardiovascular disease.
In this week's issue, Dr Jennings discusses the rates of obesity and how GLP-1 agonists may be vital in treating patients with obesity who have cardiovascular disease.
In this week's issue, Dr...
11/22/2023
Pharmacy Learning Network
douglas jennings
Talking Therapeutics
Heart Failure Happy Hour
10/20/2021
This week, Dr Jennings discusses new research that sheds more light on two new classes of heart failure drug therapies.
This week, Dr Jennings discusses new research that sheds more light on two new classes of heart failure drug therapies.
This week, Dr Jennings discusses...
10/20/2021
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
Update on COVID-19 Variants and Vaccines
06/16/2022
This week, Dr Jennings highlights 2 new articles in which investigators studied how well vaccines and previous infection protected against Omicron subvariants.
This week, Dr Jennings highlights 2 new articles in which investigators studied how well vaccines and previous infection protected against Omicron subvariants.
This week, Dr Jennings...
06/16/2022
Pharmacy Learning Network
Headshot and logo for Talking Therapeutics with Douglas Jennings, PharmD
Talking Therapeutics
The Expanding Role of Artificial Intelligence in Pharmacy
03/31/2023
In the latest installment of Talking Therapeutics, Dr Jennings discusses new artificial intelligence technology and speculates how ongoing innovation may impact pharmacy practice.
In the latest installment of Talking Therapeutics, Dr Jennings discusses new artificial intelligence technology and speculates how ongoing innovation may impact pharmacy practice.
In the latest installment of...
03/31/2023
Pharmacy Learning Network
Douglass Jennings
Talking Therapeutics
Confirmed Risks for MI and CVA With Triptan Therapy
03/12/2024
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking Therapeutics, Dr Jennings reviews triptans and their impact on myocardial infarction and cerebrovascular accidents.
In this installment of Talking...
03/12/2024
Pharmacy Learning Network

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use